ACAD
Acadia Pharmaceuticals
$20.17
+$0.43 (+2.18%)Oct 27, 2026
Key metrics
The numbers that frame ACAD today
- Market cap
- $3.48B
- P/E (TTM)
- 9.0
- EV / FCF
- 21.6
- Gross margin
- 91.1%
- EV / Sales
- 2.8
- ROIC
- 13.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $18.39
- 52wk High
- $30.96
Growth
Revenue and earnings trend for ACAD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ACAD
Is Acadia Pharmaceuticals a good buy?
Yes. Acadia Pharmaceuticals has strong quality, and it outweighs the weak momentum here. Growth looks excellent, which supports the long-term business case. We think Acadia Pharmaceuticals is selling at a fair price.
What is the market capitalization of ACAD?
Acadia Pharmaceuticals's market capitalization is $3.48B.
What is the P/E (TTM) ratio for ACAD stock?
Acadia Pharmaceuticals's P/E (TTM) ratio is 9, based on trailing earnings.
What is the 52-week high for ACAD stock?
The 52-week high for Acadia Pharmaceuticals is $30.96. The current close of $20.17 is 34.9% below that high.
What is the 52-week low for ACAD stock?
The 52-week low for Acadia Pharmaceuticals is $18.39. The current close of $20.17 is 9.7% above that low.
Does ACAD stock pay dividends?
Acadia Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ACAD?
Acadia Pharmaceuticals's Debt / Equity ratio is 0.05.